Latest filing: EP Biocomposites Ltd - 543595 - Press Release On The Financial Results For The Half Year And Year Ended March 31, 2026
ObservedCompany dossier
EP Biocomposites
BSE:EPBIO · ISIN INE0D2I01014
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
EP Biocomposites
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest ownership: promoter group 70.08% and public 29.92% as of 31 Mar 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing EP Biocomposites Ltd - 543595 - Press Release On The Financial Results For The Half Year And Year Ended March 31, 2026
BSE · financial results
Observed
Source filing EP Biocomposites Ltd - 543595 - Board Meeting Outcome for Outcome Of The Board Meeting Along With The Financial Results For The Year Ended March 31, 2026
BSE · financial results
Observed
Source filing EP Biocomposites Ltd - 543595 - Financial Results For The Year Ended March 31, 2026
BSE · financial results
Observed
Source filing EP Biocomposites Ltd - 543595 - Board Meeting Intimation for Board Meeting Scheduled To Approve The Financial Results For The Year Ended March 31, 2026
BSE · financial results
Reported financials
Full financials →Awaiting structured filing
No reconciled records in this module yet
Structured financial facts have not been reconciled.
Ownership
Full shareholding →31 Mar 2026
- Promoter group
- 70.08%
- Public
- 29.92%
- Employee trust
- N/A
Observed BSE shareholding XBRL